GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » FutureChem Co Ltd (XKRX:220100) » Definitions » Deferred Policy Acquisition Costs

FutureChem Co (XKRX:220100) Deferred Policy Acquisition Costs


View and export this data going back to 2015. Start your Free Trial

What is FutureChem Co Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


FutureChem Co Business Description

Traded in Other Exchanges
N/A
Address
2Floor, 21, Yeonmujang 3-gil, Seongdong-gu, Seoul, KOR, 04782
FutureChem Co Ltd is a radiopharmaceuticals company engaged in manufacturing related precursors chemicals, automatic synthesizer, and synthesis reagents and develops & commercializes new traces with research and development. It offers radiopharmaceuticals for diagnosing cancers, and Alzheimer's diseases; and automation modules and disposable goods, such as disposable cassettes, reagent kits, and radio-caps. It also provides peptide-based radiopharmaceuticals for radio-metal chelation and click reaction; linkers for bio-conjugation using copper-free/mediated click reaction. In addition, the company is involved in the research and development of radioisotope labeling technology; and automation devices. Further, it offers amino acids and reagents for peptides; and ionic liquids.